Spine BioPharma Revenue and Competitors
Estimated Revenue & Valuation
- Spine BioPharma's estimated annual revenue is currently $1.3M per year.
- Spine BioPharma's estimated revenue per employee is $77,500
- Spine BioPharma's total funding is $23M.
Employee Data
- Spine BioPharma has 17 Employees.
- Spine BioPharma grew their employee count by 6% last year.
Spine BioPharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Commercial Officer & Chief Operating Officer | Reveal Email/Phone |
2 | VP Commercial | Reveal Email/Phone |
3 | Controller | Reveal Email/Phone |
4 | VP Patient Access | Reveal Email/Phone |
5 | Director, Finance & Accounting | Reveal Email/Phone |
6 | Chairman & CEO | Reveal Email/Phone |
7 | Executive Assistant To CEO | Reveal Email/Phone |
8 | Clinical Operations Associate | Reveal Email/Phone |
9 | Chairman & CEO | Reveal Email/Phone |
Spine BioPharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is Spine BioPharma?
Patients around the world are struggling with debilitating back pain, trying to avoid invasive surgeries and the potential of opioid addiction. Spine Biopharma has developed a non-surgical solution that will remove pain and restore functionality, without having to use opioids.
keywords:N/A
$23M
Total Funding
17
Number of Employees
$1.3M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Spine BioPharma News
U.S.-based Spine BioPharma has been given permission from the U.S. Food and Drug Administration to bypass the second phase and go directly...
Spine BioPharma specializes in non-surgical therapies that will reduce pain, restore function and slow or stop pathological spinal disease...
Spine Biopharma completed a $13 million round of Series B equity financing this week. The financing will support the development of Spine's...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.5M | 17 | -62% | N/A |
#2 | $1.5M | 17 | -11% | N/A |
#3 | $2.1M | 17 | -26% | N/A |
#4 | $4.9M | 17 | -19% | $19.4M |
#5 | $7.5M | 17 | -19% | $56.6M |